Prevent Blindness, the nation's leading nonprofit eye health organization, is announcing Dec. 2-8, 2024, as its fourth annual Geographic Atrophy (GA) Awareness Week. GA is an advanced form of dry ...
Dramatic 95% Reduction of Cognitive Decline in CT1812-treated Patients with Lower Plasma p-tau217 Correlated with Improvements in Key Indicators of ...
Avirmax Biopharma, Inc., a leader in the development of innovative gene therapies, today announced that the first patient has been successfully dosed in the Phase I/IIa clinical trial of ABI-110, the ...